These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23813298)

  • 21. Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.
    Tazen S; Figueroa K; Kwan JY; Goldman J; Hunt A; Sampson J; Gutmann L; Pulst SM; Mitsumoto H; Kuo SH
    JAMA Neurol; 2013 Oct; 70(10):1302-4. PubMed ID: 23959108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative multiplex dosage analysis in spinocerebellar ataxia type 2 patients.
    Calì F; Chiavetta V; Ragalmuto A; Vinci M; Ruggeri G; Schinocca P; Romano V
    Genet Mol Res; 2013 Apr; 12(2):1176-81. PubMed ID: 23661442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
    Pulst SM; Santos N; Wang D; Yang H; Huynh D; Velazquez L; Figueroa KP
    Brain; 2005 Oct; 128(Pt 10):2297-303. PubMed ID: 16000334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germ-line CAG repeat instability causes extreme CAG repeat expansion with infantile-onset spinocerebellar ataxia type 2.
    Vinther-Jensen T; Ek J; Duno M; Skovby F; Hjermind LE; Nielsen JE; Nielsen TT
    Eur J Hum Genet; 2013 Jun; 21(6):626-9. PubMed ID: 23047744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SCA2 predictive testing in Cuba: challenging concepts and protocol evolution.
    Cruz-Mariño T; Vázquez-Mojena Y; Velázquez-Pérez L; González-Zaldívar Y; Aguilera-Rodríguez R; Velázquez-Santos M; Estupiñán-Rodríguez A; Laffita-Mesa JM; Almaguer-Mederos LE; Paneque M
    J Community Genet; 2015 Jul; 6(3):265-73. PubMed ID: 25893506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.
    Geschwind DH; Perlman S; Figueroa CP; Treiman LJ; Pulst SM
    Am J Hum Genet; 1997 Apr; 60(4):842-50. PubMed ID: 9106530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with ATXN2 CAG/CAA repeat intergenerational instability in Spinocerebellar ataxia type 2.
    Almaguer-Mederos LE; Mesa JML; González-Zaldívar Y; Almaguer-Gotay D; Cuello-Almarales D; Aguilera-Rodríguez R; Falcón NS; Gispert S; Auburger G; Velázquez-Pérez L
    Clin Genet; 2018 Oct; 94(3-4):346-350. PubMed ID: 29756284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
    Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
    Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular analysis of the CAG repeat among patients with Type-2 spinocerebellar ataxia in the Mexican population].
    Magaña JJ; Vergara MD; Sierra-Martínez M; García-Jiménez E; Rodríguez-Antonio F; Gómez Mdel R; Valdés-Flores M; Cisneros B
    Gac Med Mex; 2008; 144(5):413-8. PubMed ID: 19043961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis.
    Mutesa L; Pierquin G; Segers K; Vanbellinghen JF; Gahimbare L; Bours V
    J Trop Pediatr; 2008 Oct; 54(5):350-2. PubMed ID: 18499737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in the molecular diagnosis of Machado-Joseph disease.
    Maciel P; Costa MC; Ferro A; Rousseau M; Santos CS; Gaspar C; Barros J; Rouleau GA; Coutinho P; Sequeiros J
    Arch Neurol; 2001 Nov; 58(11):1821-7. PubMed ID: 11708990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinocerebellar ataxia type 2 has multiple ancestral origins.
    Sena LS; Furtado GV; Pedroso JL; Barsottini O; Cornejo-Olivas M; Nóbrega PR; Braga Neto P; Soares DMB; Vargas FR; Godeiro C; Medeiros PFV; Camejo C; Toralles MBP; Fagundes NJR; Jardim LB; Saraiva-Pereira ML;
    Parkinsonism Relat Disord; 2024 Mar; 120():105985. PubMed ID: 38181536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variance in the spinocerebellar ataxia type 2 (ATXN2) gene in children with severe early onset obesity.
    Figueroa KP; Farooqi S; Harrup K; Frank J; O'Rahilly S; Pulst SM
    PLoS One; 2009 Dec; 4(12):e8280. PubMed ID: 20016785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ataxin-2 repeat-length variation and neurodegeneration.
    Ross OA; Rutherford NJ; Baker M; Soto-Ortolaza AI; Carrasquillo MM; DeJesus-Hernandez M; Adamson J; Li M; Volkening K; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Woodruff BK; Knopman DS; White CL; Van Gerpen JA; Meschia JF; Mackenzie IR; Boylan K; Boeve BF; Miller BL; Strong MJ; Uitti RJ; Younkin SG; Graff-Radford NR; Petersen RC; Wszolek ZK; Dickson DW; Rademakers R
    Hum Mol Genet; 2011 Aug; 20(16):3207-12. PubMed ID: 21610160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinocerebellar ataxia type 2 (SCA2): identification of early brain degeneration in one monozygous twin in the initial disease stage.
    Hoche F; Balikó L; den Dunnen W; Steinecker K; Bartos L; Sáfrány E; Auburger G; Deller T; Korf HW; Klockgether T; Rüb U; Melegh B
    Cerebellum; 2011 Jun; 10(2):245-53. PubMed ID: 21128038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, and positron emission tomography findings.
    Wang JL; Xiao B; Cui XX; Guo JF; Lei LF; Song XW; Shen L; Jiang H; Yan XX; Pan Q; Long ZG; Xia K; Tang BS
    Mov Disord; 2009 Oct; 24(13):2007-11. PubMed ID: 19672991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12.
    Srivastava AK; Choudhry S; Gopinath MS; Roy S; Tripathi M; Brahmachari SK; Jain S
    Ann Neurol; 2001 Dec; 50(6):796-800. PubMed ID: 11761478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
    Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O
    Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.